about
Continual Reassessment and Related Dose-Finding DesignsContinual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies.Competing designs for phase I clinical trials: a review.Phase I studies of chemotherapeutic agents in cancer patients: a review of the designs.Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.Phase 1 trial design: is 3 + 3 the best?Embracing model-based designs for dose-finding trials.Continual reassessment and related designs in dose-finding studiesRetrospective robustness of the continual reassessment method.Posterior maximization and averaging for Bayesian working model choice in the continual reassessment method.Application of New Designs in Phase I TrialsApplication of New Designs in Phase I TrialsApplication of New Designs in Phase I Trials
P2860
Q30431500-CC325CE3-D439-4AA8-BB35-7F8F63E3B76CQ31125934-D7681916-760C-4A3B-AB1D-60CB783686E2Q33368246-AA70CD76-97AE-4848-AC92-B97EF3DBB603Q34849945-AB737A0F-0F64-4290-BCDB-64C93060824DQ36621961-35447845-6E1A-4127-99ED-161ADFD22819Q38097422-7FD00B60-65F1-49A8-97FC-FCD386479097Q38222466-D953D638-7889-42DA-8F27-043E30B43635Q38700689-470569C0-6CF1-4213-99AB-E8C40BAE38BBQ42172755-78CEB75C-3309-4B7F-A1F4-A0B578328E44Q42933068-71CB906A-7661-4BE5-81D1-D224A16F0DDDQ45023344-AB5CA932-4B0C-4ECD-8F76-9187D501DC4CQ57338824-7592FFCB-FA10-4679-98A3-508A9D9BAA1CQ57338825-FE30A578-217B-4944-96EE-C9E4F979CBADQ57338826-480E0735-F155-4994-94C1-4D1A00075F80
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Another look at two phase I clinical trial designs.
@en
type
label
Another look at two phase I clinical trial designs.
@en
prefLabel
Another look at two phase I clinical trial designs.
@en
P1476
Another look at two phase I clinical trial designs.
@en
P2093
O'Quigley J
P304
2683-90; discussion 2691-2
P356
10.1002/(SICI)1097-0258(19991030)18:20<2683::AID-SIM193>3.0.CO;2-Z
P407
P577
1999-10-01T00:00:00Z